Hepatology International, 1936-0533

Journal

Related Publications
  1. Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis

    Wang, Q., You, H., Ou, X., Zhao, X., Sun, Y., Wang, M., Wang, P., Wang, Y., Duan, W., Wang, X., Wu, S., Kong, Y., Saxena, R., Gouw, A. S. H. & Jia, J., Nov-2019, In : Hepatology International. 13, 6, p. 766-776 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge

    Zweers, S. J., de Vries, E. M., Lenicek, M., Tolenaars, D., de Waart, D. R., Koelfat, K. V. K., Groen, A. K., Damink, S. W. M. O., Beuers, U., Ponsioen, C., Jansen, P. L. M. & Schaap, F. G., Jan-2017, In : Hepatology International. 11, 1, p. 132-140 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Determine effect of weight loss on serum level of inflammatory cytokines IL 1 IL 6 CRP and TNF α in obese patients with fatty liver disease

    Somi, M. H., Alizadeh, B. Z., Boostani, K. & Khaneshi, M., 1-Mar-2015, In : Hepatology International. 9, 1, p. 363-364 2 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (3) »

ID: 31608634